ロード中...
Altered pathways and colorectal cancer prognosis
The identification of molecular markers with prognostic value in colorectal cancer is a challenging task that is needed to define therapeutic guidelines. Clinical factors are insufficient to identify those patients with stage II at risk of relapse or those patients with stage III at low risk. There...
保存先:
出版年: | BMC Med |
---|---|
主要な著者: | , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2015
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4389340/ https://ncbi.nlm.nih.gov/pubmed/25885526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0307-6 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|